San Diego, CA, United States of America

Andiliy Gokching Lai

This inventor holds 19 USPTO granted patents and 11 published patent applications and 8 EPO patents, primarily in Kinase Modulation. Top assignees: Ambit Biosciences Corporation, Genentech, Inc., Seragon Pharmaceuticals, Inc.. Active years: 2010-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Andiliy Gokching Lai. Retrieved from https://idiyas.com/inventor/andiliy-gokching-lai

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 19 

% Patents Active = 63.2

 

Average Co-Inventor Count = 6.7

ph-index = 7

Forward Citations = 168(Granted Patents)


Company Filing History:


Years Active: 2010-2023

Loading Chart...
Loading Chart...
Areas of Expertise:
Farnesoid X Receptor
RAF Kinase Modulator
Estrogen Receptor
Heterocyclic Compounds
Tetracyclic Inhibitors
Fluorinated Modulators
3-Carboxamido Isoxazoles
Isoxazolyl Urea Derivatives
Kinase Modulators
Drug Discovery
Pharmaceutical Applications
Therapeutic Targets
19 patents (USPTO):Explore Patents

Sure, I can help you with that. Let's start crafting your article about inventor Andiliy Gokching Lai:

Title: The Innovative Journey of Andiliy Gokching Lai

Introduction:

Hailing from San Diego, CA, Andiliy Gokching Lai is a prolific inventor with an impressive track record of 18 patents to his name. His groundbreaking work in the field of farnesoid X receptor agonists has paved the way for advancements in treating a variety of conditions and diseases.

Latest Patents:

Lai's latest patents focus on compounds that act as farnesoid X receptor agonists. These compounds, along with the methods of producing them, pharmaceutical compositions, and their uses in treating conditions associated with farnesoid X receptor activity, represent a significant contribution to the medical field.

Career Highlights:

Throughout his career, Lai has made significant contributions to companies such as Ambit Biosciences Corporation and Seragon Pharmaceuticals, Inc. His innovative work has helped these companies push the boundaries of scientific research and development, ultimately leading to improved healthcare solutions for patients worldwide.

Collaborations:

Lai has had the opportunity to collaborate with industry leaders such as Nicholas D. Smith and Steven P. Govek. Together, they have worked tirelessly to bring cutting-edge therapies to market, setting new standards for innovation in the pharmaceutical industry.

Conclusion:

In conclusion, Andiliy Gokching Lai's dedication to innovation and his passion for scientific discovery have established him as a leading figure in the field of medicinal chemistry. His patented inventions have not only improved the lives of countless individuals but have also set the stage for future breakthroughs in healthcare technology and treatment methods.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…